Biolex

We are a clinical-stage biopharmaceutical company that uses our patented LEX SystemSM to develop follow-on biologics, hard-to-make therapeutic proteins and monoclonal antibodies that have been optimized to enhance their efficacy and potency. The LEX System is a novel technology that genetically transforms the aquatic plant Lemna to enable the production of biologic product candidates.

CEO: Jan Turek Contact Info: 158 Credle Street, Pittsboro, NC 27312 Website: www.biolex.com LinkedIn: Biolex on LinkedIn